Australia markets closed

InMed Pharmaceuticals Inc. (INM)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.2949+0.0199 (+7.24%)
At close: 04:00PM EDT
0.3001 +0.01 (+1.76%)
After hours: 06:13PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
5,626
4,136
1,089
0
0
Cost of revenue
3,421
2,733
545.889
0
-
Gross profit
2,205
1,403
543.546
0
-
Operating expenses
Research development
3,182
3,732
7,283
5,338
5,811
Selling general and administrative
5,446
5,848
6,867
4,479
3,227
Total operating expenses
8,847
9,782
14,335
9,938
9,151
Operating income or loss
-6,642
-8,379
-13,792
-9,938
-9,151
Interest expense
-
-
0
360.35
0
Total other income/expenses net
-5.605
-48.175
-4,904
79.527
82.187
Income before tax
-6,074
-7,935
-18,600
-10,203
-8,939
Income tax expense
1.8
13.1
0
-
-
Income from continuing operations
-6,076
-7,948
-18,600
-10,203
-8,939
Net income
-6,076
-7,948
-18,600
-10,203
-8,939
Net income available to common shareholders
-6,076
-7,948
-18,600
-10,203
-8,939
Basic EPS
0.05
-3.25
-1.33
-37.96
-42.75
Diluted EPS
0.05
-3.25
-1.33
-37.96
-42.75
Basic average shares
3,064
2,448
14,021
268.793
208.828
Diluted average shares
3,064
2,448
14,021
268.793
208.828